Related Experiment Video

Updated: Apr 28, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.4K

Interference of Skp2 effectively inhibits the development and metastasis of colon carcinoma

Haijin Chen1, Xiaodong Mo2, Jinlong Yu1

  • 1Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.

Molecular Medicine Reports
|June 11, 2014
PubMed

Insights

This study shows that inhibiting S-phase kinase-associated protein 2 (Skp2) through RNA interference reduces colon cancer cell proliferation and migration. Depleting Skp2 also increases apoptosis and improves survival rates in mouse models, highlighting Skp2 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colon cancer is a prevalent digestive system malignancy.
  • S-phase kinase-associated protein 2 (Skp2) is implicated in various cancers.
  • Understanding Skp2's role in colon carcinoma is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the role of Skp2 in colon carcinoma progression.
  • To determine if Skp2 depletion using RNA interference (RNAi) can inhibit colon cancer cell proliferation and migration.
  • To explore Skp2 as a potential therapeutic target for colon cancer.

Main Methods:

  • Small interfering RNA (siRNA) targeting Skp2 was designed and validated in SW620 colon cancer cells.
  • Quantitative polymerase chain reaction (qPCR) and western blot analysis were used to assess Skp2 mRNA and protein expression.
  • In vitro proliferation, apoptosis, and cell cycle assays were performed.
  • In vivo experiments involved lentiviral Skp2-RNAi in nude mice, followed by immunohistochemistry and tumorigenicity studies.

Main Results:

  • Skp2-siRNA significantly inhibited SW620 cell proliferation (P<0.01) and induced G0/G1 phase arrest (P<0.01).
  • Skp2 depletion led to increased apoptosis and elevated p27 protein levels.
  • In vivo, Skp2 inhibition via lentiviral RNAi markedly reduced Skp2 expression and significantly increased survival rates in nude mice.
  • Tumorigenicity experiments confirmed the anti-cancer effects of Skp2 inhibition.

Conclusions:

  • Skp2 plays a significant role in the progression of colon cancer.
  • Interference with Skp2 expression effectively inhibits colon cancer cell proliferation and induces apoptosis both in vitro and in vivo.
  • Targeting Skp2 offers a promising strategy for early diagnosis and novel molecular therapy for colon cancer.

More Related Videos

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer06:19

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

9.9K
In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

34.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
2.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K